Wednesday, September 6, 2017
MabVax Therapeutics Hires Greenhill & Co. As It Seeks Sale
San Diego-based oncology drug developer MabVax Therapeutics announced today that it has hired Greenhill & Co. as its investment banking advisor, as it explores "strategic alternatives", including a full company sale, licensing agreements or asset sale coupled with a reverse merger for the company. MabVax--which had announced it was seeking a sale in August--had earlier said it had hired a banker, but had not announced who would be helping it with its efforts. MabVax said that Greenhill will be assisting the companyin evaluating transaction options currently being considered as well as identifying new opportunities which could include the acquisition of MabVax by another company, the sale or divestiture of specific assets coupled with a reverse merger, merging with another company, or licensing of selected technologies.